<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.1//EN" "ep-patent-document-v1-1.dtd">
<ep-patent-document id="EP02703474B8W1" file="EP02703474W1B8.xml" lang="en" country="EP" doc-number="1374873" kind="B8" correction-code="W1" date-publ="20050629" status="c" dtd-version="ep-patent-document-v1-1">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTR............................</B001EP><B005EP>J</B005EP><B007EP>DIM350 (Ver 2.1 Jan 2001)
 2999001/0</B007EP></eptags></B000><B100><B110>1374873</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20050629</date></B140><B150><B151>W1</B151><B153>73</B153><B155><B1551>DE</B1551><B1552>Bibliographie</B1552><B1551>EN</B1551><B1552>Bibliography</B1552><B1551>FR</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>02703474.3</B210><B220><date>20020228</date></B220><B240><B241><date>20030929</date></B241></B240><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>01104882</B310><B320><date>20010228</date></B320><B330><ctry>CN</ctry></B330></B300><B400><B405><date>20050629</date><bnum>200526</bnum></B405><B430><date>20040102</date><bnum>200401</bnum></B430><B450><date>20050427</date><bnum>200517</bnum></B450><B452EP><date>20041012</date></B452EP><B480><date>20050629</date><bnum>200526</bnum></B480></B400><B500><B510><B516>7</B516><B511> 7A 61K  31/7008 A</B511><B512> 7A 61P  35/00   B</B512></B510><B540><B541>de</B541><B542>VERWENDUNG VON N-ACETYL-D-GLUCOSAMIN BEI DER HERSTELLUNG EINES ARZNEIMITTELS ZUR UNTERDRÜCKUNG DER NEBENWIRKUNGEN VON STRAHLENTHERAPIE UND CHEMOTHERAPIE</B542><B541>en</B541><B542>THE USE OF N-ACETYL-D-GLUCOSAMINE IN THE MANUFACTURE OF PHARMACEUTICAL USEFUL FOR SUPRESSING SIDE-EFFECT OF RADIOTHERAPY AND CHEMOTHERAPY</B542><B541>fr</B541><B542>UTILISATION DE LA N-ACETYL-D-GLUCOSAMINE DANS LA PREPARATION DE COMPOSITIONS PHARMACEUTIQUES UTILISEES DANS LA SUPPRESSION DES EFFETS SECONDAIRES CAUSES PAR LA RADIOTHERAPIE ET LA CHIMIOTHERAPIE</B542></B540><B560><B561><text>WO-A-93/14765</text></B561><B561><text>WO-A-93/18775</text></B561><B561><text>CN-A- 1 156 026</text></B561><B561><text>CN-A- 1 156 027</text></B561><B561><text>CN-A- 1 156 028</text></B561><B565EP><date>20040625</date></B565EP></B560></B500><B700><B720><B721><snm>XU, Qiwang</snm><adr><str>No. 30 Gaotanyan Street,
Shapingba District</str><city>Chongqing 400038</city><ctry>CN</ctry></adr></B721><B721><snm>LIU, Junkang</snm><adr><str>No. 30 Gaotanyan Street,
Shapingba District</str><city>Chongqing 400038</city><ctry>CN</ctry></adr></B721><B721><snm>YUAN, Zetao</snm><adr><str>No. 30 Gaotanyan Street,
Shapingba District</str><city>Chongqing 400038</city><ctry>CN</ctry></adr></B721></B720><B730><B731><snm>Third Military Medical University Chinese People's Liberation Army P.R. of China</snm><iid>04202000</iid><irf>EP28707/019/kj</irf><syn>Military Medical University Chinese People's Liberation Army P.R. of China, Third</syn><syn>Chinese People's Liberation Army P.R. of China, Third Military Medical University</syn><syn>P.R. of China, Third Military Medical University Chinese People's Liberation Army</syn><adr><str>No. 30-Gaotanyan Street,
Shapingba District</str><city>Chongqing 400038</city><ctry>CN</ctry></adr></B731><B731><snm>Bio-Wave Institute of Suzhou Hi-Tech New District Corporation, Ltd</snm><iid>04202010</iid><irf>EP28707/019/kj</irf><adr><str>5F No. 125-Binghe Street,
New District of Suzhou</str><city>Jiangsu 215011</city><ctry>CN</ctry></adr></B731><B731><snm>Beijing Sino-Hongkong Dafu Science &amp; Technology of Biowave Co., Ltd.</snm><iid>05234110</iid><irf>EP28707/019/kj</irf><adr><str>Room 102, Xiaoyuyang Hotel,
North of Erhuan Road,
Pinggu Town,
Pinggu District</str><city>Beijing 101200</city><ctry>CN</ctry></adr></B731></B730><B740><B741><snm>Grünecker, Kinkeldey, 
Stockmair &amp; Schwanhäusser
Anwaltssozietät</snm><iid>00100721</iid><adr><str>Maximilianstrasse 58</str><city>80538 München</city><ctry>DE</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry><ctry>TR</ctry></B840><B844EP><B845EP><ctry>AL</ctry><date>20030929</date></B845EP><B845EP><ctry>LT</ctry><date>20030929</date></B845EP><B845EP><ctry>LV</ctry><date>20030929</date></B845EP><B845EP><ctry>MK</ctry><date>20030929</date></B845EP><B845EP><ctry>RO</ctry><date>20030929</date></B845EP><B845EP><ctry>SI</ctry><date>20030929</date></B845EP></B844EP><B860><B861><dnum><anum>CN2002000119</anum></dnum><date>20020228</date></B861></B860><B870><B871><dnum><pnum>WO2002067946</pnum></dnum><date>20020906</date><bnum>200236</bnum></B871></B870></B800></SDOBI>
</ep-patent-document>
